Weinberger Asset Management’s Pfizer PFE Stock Holding History

Weinberger Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$291K	Sell	11,628 -74	-0.6%	-$1.94K	0.09%	81
2026 Q1	$329K	Buy	11,702 +10	+0.1%	+$266	0.12%	74
2025 Q4	$291K	Buy	11,692 +60	+0.5%	+$1.51K	0.1%	79
2025 Q3	$296K	Sell	11,632 -3,483	-23%	-$86K	0.11%	73
2025 Q2	$366K	Sell	15,115 -1,693	-10%	-$39.5K	0.14%	68
2025 Q1	$426K	Sell	16,808 -296	-2%	-$7.75K	0.18%	62
2024 Q4	$454K	Sell	17,104 -45	-0.3%	-$1.22K	0.19%	61
2024 Q3	$496K	Buy	17,149 +4	+0%	+$117	0.21%	60
2024 Q2	$480K	Sell	17,145 -496	-3%	-$13.7K	0.23%	58
2024 Q1	$490K	Sell	17,641 -4,315	-20%	-$120K	0.24%	56
2023 Q4	$632K	Sell	21,956 -759	-3%	-$22.9K	0.33%	46
2023 Q3	$753K	Buy	22,715 +299	+1%	+$10.6K	0.43%	43
2023 Q2	$822K	Sell	22,416 -586	-3%	-$22.8K	0.45%	42
2023 Q1	$938K	Hold	23,002	–	–	0.55%	38
2022 Q4	$1.18M	Sell	23,002 -200	-0.9%	-$9.59K	0.72%	31
2022 Q3	$1.02M	Buy	23,202 +212	+0.9%	+$10.3K	0.7%	31
2022 Q2	$1.21M	Buy	+22,990	New	+$1.17M	0.8%	29

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Weinberger Asset Management's PFE Position: Q2 2026 in Review

Weinberger Asset Management reduced its Pfizer (PFE) stake by 0.63% in Q2 2026, selling an estimated $1.94K and leaving 11,628 shares worth $291K. The position accounts for 0.09% of the portfolio, ranked #81.

Weinberger Asset Management first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.21M in Q2 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Weinberger Asset Management held 11,628 shares of Pfizer worth $291K as of Q2 2026.
Weinberger Asset Management sold 74 Pfizer shares in Q2 2026, an estimated $1.94K.
Pfizer made up 0.09% of Weinberger Asset Management's portfolio in Q2 2026, its #81 holding.
Weinberger Asset Management first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
Weinberger Asset Management's Pfizer position peaked at $1.21M in Q2 2022.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Weinberger Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.